Insulin vials vs. insulin cartridges: Further cost considerations

被引:9
|
作者
Al-Sharayri, Mohammad G. [1 ]
Alsabrah, Tariq M. [2 ]
Aljbori, Tareq M. [2 ]
Abu-Rumman, Ala'a Eddeen K. [2 ]
机构
[1] Univ York, York YO10 5DD, N Yorkshire, England
[2] Univ Bradford, Bradford BD7 1DP, W Yorkshire, England
关键词
Insulin; Vial; Cartridge; Wastage; Cost; PEN DEVICES;
D O I
10.1016/j.jsps.2012.07.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Scope: Many studies have provided evidence that favor the use of insulin pens over traditional insulin vials due to lower overall costs. The cost of insulin in the Royal Medical Services in Jordan is subject to other considerations due to the favorable tender prices and the process of dispensing of insulin within the Royal Medical Services. Objective: To highlight further cost considerations associated with the wastage in the use of insulin vials and cartridges in the Jordanian Royal Medical Services. Methods: Two random samples were selected from prescriptions dispensed for diabetic patients using insulin in January 2012 from the outpatient pharmacy in Al-Hussein Hospital, King Hussein Medical Center, Amman, Jordan. First sample was selected from prescriptions of patients using vials; second sample was selected from prescriptions of patients using pens and cartridges. Average costs for insulin and wastage were calculated per patient from the Royal Medical Services perspective. Results: The average direct cost per patient using vials was JD 5.197 and for those using cartridges was JD 22.135. The average wasted quantity per patient in the first sample was more than ten times that of the second sample. The cost of the average wasted quantity per patient in the first sample (1.022 JD) was more than the double that in the second sample (0.441 JD). Conclusion: Although, the direct cost of insulin per patient by using vials was lower than cartridges, there was a substantial reduction in the cost of wastage by using the cartridges in the Jordanian Royal Medical Services outpatients. (C) 2012 King Saud University. Production and hosting by Elsevier B.V. All rights reserved.
引用
收藏
页码:225 / 227
页数:3
相关论文
共 50 条
  • [1] Differential Insulin Concentrations in the Injected NPH from Vials and Cartridges: Dependency on Prior Resuspension
    Lucidi, Paola
    Porcellati, Francesca
    Andreoli, Anna Marinelli
    Candeloro, Paola
    Cioli, Patrizia
    Bolli, Geremia B.
    Fanelli, Carmine G.
    DIABETES, 2016, 65 : A243 - A244
  • [2] COST ANALYSIS OF METFORMIN VS. INSULIN IN MANAGEMENT OF GESTATIONAL DIABETES
    Lai, Jasmine
    Tan, Justin
    Cheng, Yvonne
    Alexandra, Gladys Ramos
    Liddell, Jennifer
    Caughey, Aaron
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2008, 199 (06) : S231 - S231
  • [3] Comparative analysis of insulin glargine vs. insulin detemir: A cost-minimization study applicable to Colombia
    Fragozo, Argemiro
    Fernanda Puerta, Maria
    Diego Misas, Juan
    BIOMEDICA, 2015, 35 (02): : 204 - 211
  • [4] Do insulin cartridges really provide a lower risk of potential diabetes complications than traditional vials?
    Al-Sharayri, Mohammad G.
    Aljbori, Tariq M.
    Migdadi, Qusai M.
    Al-Omoush, Marwa B.
    Jaarah, Ayman R.
    SAUDI PHARMACEUTICAL JOURNAL, 2014, 22 (04) : 373 - 375
  • [5] Compatibility of insulin pens and cartridges
    Holleman, F
    Vermeijden, JW
    Kuck, EM
    Hoekstra, JBL
    Erkelens, DW
    LANCET, 1997, 350 (9091): : 1601 - 1602
  • [6] Increase in the capacity of insulin cartridges
    Solignac, M
    DIABETES & METABOLISM, 1999, 25 (06)
  • [7] Insulin monotherapy vs. combination therapy
    Ebell, MH
    AMERICAN FAMILY PHYSICIAN, 2005, 71 (05) : 899 - 899
  • [8] The Impact of Insulin Glargine vs. Human Insulin Use on Cancer Incidence
    Geier, Anne S.
    Wellmann, Ina
    Wellmann, Juergen
    Franklin, Jessica M.
    Kajueter, Hiltraud
    Heidinger, Oliver
    Hempel, Georg
    Hense, Hans-Werner
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 : 266 - 267
  • [9] Short-acting insulin analogues vs. human insulin for diabetes
    Schooff, M
    Ehlers, K
    AMERICAN FAMILY PHYSICIAN, 2005, 72 (05) : 805 - 807
  • [10] Comparative Effectiveness of Insulin vs. Combination Insulin and Sulfonylurea on Cardiovascular Outcomes
    Roumie, Christianne L.
    Greevy, Robert A.
    Grijalva, Carlos G.
    Hung, Adriana M.
    Liu, Xulei
    Murff, Harvey J.
    Elasy, Tom A.
    Griffin, Marie R.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2013, 22 : 201 - 201